James H. Sabry, CEO at CYTOKINETICS INC (CYTK), sold 7,000 shares at $7.93 ($55K) on 2007-02-01, disclosed to the SEC on 2007-02-02.
Scheduled sale ($55k) by CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.75 | 100 | $775 | 1.4% |
| 2 | $7.76 | 100 | $776 | 1.4% |
| 3 | $7.77 | 200 | $2K | 2.8% |
| 4 | $7.78 | 100 | $778 | 1.4% |
| 5 | $7.79 | 200 | $2K | 2.8% |
| 6 | $7.81 | 300 |
| $2K |
| 4.2% |
| 7 | $7.82 | 500 | $4K | 7.1% |
| 8 | $7.83 | 1,000 | $8K | 14.2% |
| 9 | $7.84 | 100 | $784 | 1.4% |
| 10 | $7.85 | 500 | $4K | 7.1% |
| 11 | $7.86 | 300 | $2K | 4.3% |
| 12 | $7.87 | 500 | $4K | 7.1% |
| 13 | $7.91 | 100 | $791 | 1.4% |
| 14 | $7.93 | 200 | $2K | 2.9% |
| 15 | $7.95 | 728 | $6K | 10.5% |
| 16 | $7.96 | 100 | $796 | 1.4% |
| 17 | $7.97 | 672 | $5K | 9.7% |
| 18 | $7.98 | 100 | $798 | 1.4% |
| 19 | $8.00 | 300 | $2K | 4.3% |
| 20 | $8.01 | 700 | $6K | 10.1% |
| 21 | $8.02 | 100 | $802 | 1.5% |
| 22 | $8.08 | 100 | $808 | 1.5% |
| Total | $7.89 avg | 7,000 | $55K | 100% |
| Filing → |
| CYTK | SELL | 2010-05-14 | $30K | — | Filing → |
| CYTK | SELL | 2010-04-28 | $32K | — | Filing → |
| CYTK | SELL | 2010-04-01 | $32K | — | Filing → |